Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  DexCom, Inc.    DXCM   US2521311074

DEXCOM, INC.

 (DXCM)

3
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
DexCom, Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales48,676,399,9130167213
Operating income (EBITDA)-42,9-41,1-49,1-24,00,9835,0
Operating profit (EBIT)-45,3-44,8-55,7-38,8-17,314,1
Pre-Tax Profit (EBT)---54,8---
Net income-55,2-44,7-54,5-39,1-17,613,1
EPS ( $)-0,97-0,68-0,79-0,56-0,230,18
Dividend per Share ( $)------
Yield------
Announcement Date03/03/2011
09:01pm
02/23/2012
09:05pm
02/21/2013
09:01pm
---
Finances - Leverage
DexCom, Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance--41,7---
Operating income (EBITDA)-42,9-41,1-49,1-24,00,9835,0
Leverage
(Debt/EBITDA)
------
Capital Expenditure6,868,019,5011,613,4-
Book Value Per Share (BVPS)--1,10 $---
Cash Flow per Share------
Announcement Date03/03/2011
09:01pm
02/23/2012
09:05pm
02/21/2013
09:01pm
---
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 1 502 M$ -
Company Value - 1 502 M$
Valuation 2013e 2014e
PER (Price / EPS)
Capitalization / Revenue 11,5x 9,00x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -29,7% -10,4%
operating laverage (Delta EBIT / Delta Sales) 0,99x 1,98x
Net Margin (Net Profit / Revenue) -30,0% -10,6%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   8,89% 8,03%
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
DexCom, Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.